(NasdaqGM:CDT), Award-winning Agility Life Sciences brings a proven track record in drug formulation for a number of pharmaceutical and biotechnology clients. NAPLES, Fla. and CAMBRIDGE, United Kingdom, Jan. 22, 2025 (GLOBE NEWSWIRE) — Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company“), today announced that it has entered into a strategic services agreement with formulation […]

(NasdaqGM:VSAT), CARLSBAD, Calif., Jan. 22, 2025 (GLOBE NEWSWIRE) — Viasat, Inc. (NASDAQ: VSAT), a global leader in satellite communications, today announced a restructuring of its Senior Executive Team to better position the company for long-term growth. Effective today, January 22, Craig Miller, currently President of Global Space Networks, will become Senior Vice President, Strategic Initiatives.

WALTHAM, Mass., Jan. 22, 2025 (GLOBE NEWSWIRE) — Infinidat, a leading provider of enterprise storage solutions, today announced that it has been named to the 2025 Cloud 100 list by CRN(R), a brand of The Channel Company. The company is recognized in the “Cloud Storage” category of this prestigious CRN list for Infinidat's hybrid multi-cloud

(NASDAQ:PALI), Live webcast on Wednesday, January 29th at 2:20 PM ET Carlsbad, CA, Jan. 22, 2025 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced that JD Finley, Chief

(NASDAQ:ZJK), Shenzhen, China, Jan. 22, 2025 (GLOBE NEWSWIRE) — ZJK Industrial Co. Ltd. (NASDAQ: ZJK) (“ZJK Industrial” or the “Company”), a high-tech precision parts and hardware manufacturer for artificial intelligence (AI) infrastructure and smart technologies, is pleased to announce its participation in The Microcap Conference 2025, the premier event for growth-focused companies and investors. The

(NASDAQ:HEPA), EDISON, N.J., Jan. 22, 2025 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that has been developing a treatment for non-alcoholic steatohepatitis (“NASH”), hepatocellular carcinoma (“HCC”), and other chronic liver diseases, announced the launch of a “best efforts” public offering of 27,692,310 shares of common stock (or pre-funded warrants in

(NASDAQ:PRPH), Transaction Eliminates More Than $20 Million in Debt, and Other Financial Obligations, Provides $2 million in Cash and Significantly Enhances the Company's Balance Sheet and Liquidity The Company will review with shareholders at 2:00 p.m. EST, details below. GARDEN CITY, NY, Jan. 22, 2025 (GLOBE NEWSWIRE) — ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or

(NASDAQ:SCLX), PALO ALTO, Calif., Jan. 22, 2025 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and, following the formation of its proposed joint venture with IPMC Company, in neurodegenerative and

(NASDAQ:PLRX), Dr. Imbert brings 25 years of strategic clinical to commercial-stage manufacturing and drug development experience SOUTH SAN FRANCISCO, Calif., Jan. 22, 2025 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage biotechnology company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases, today announced the appointment

ORLANDO, Fla., Jan. 22, 2025 (GLOBE NEWSWIRE) — Arnie's, a bold new natural wellness brand inspired by Arnold Palmer's legacy of performance, embodies the unstoppable spirit that made him a global icon. Created in partnership with Arnold Palmer Enterprises and leading CBD Manufacturer Naternal, Arnie's debuts with a premium collection of topicals designed to help